As of October 2024, nearly 68 percent of insured people in Massachusetts had public or private plans that covered medications to treat obesity the highest share of any state, according to a report by the Robert Wood Johnson Foundation, a prominent philanthropy
In general: GLP-1 medicines are approved and available in all three countries Many people get these medicines through private doctors Public healthcare usually has strict rules about who can get the medicine paid for Denmark: Progressive Access with Lifestyle Focus Denmark is one of the Nordic countries most open to using GLP-1 medicines for weight loss
This amount is modest compared to dietary intake from protein-rich foods or standalone glycine supplements, which often use 3-5 grams daily
They can cause severe abdominal pain, cramping, swelling, and an inability to have a bowel movement or pass gas
The short version: Retatrutide is a synthetic 39-amino-acid peptide engineered to activate three metabolic hormone receptors at once the GLP-1 receptor, the GIP receptor, and the glucagon receptor